Question follow-through · 1835
Health Services: Women
To ask the Secretary of State for Health and Social Care, what the (a) start and (b) target completion date are for the redesign of clinical pathways for heavy menstrual bleeding, urogynaecology and menopause; and which body will be responsible for report
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 15 May 2026
- Target answer date
- 19 May 2026
- Answer
- 1 Jun 2026 · 17 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
15 May 2026
Question tabled
To ask the Secretary of State for Health and Social Care, what the (a) start and (b) target completion date are for the redesign of clinical pathways for heavy menstrual bleeding, urogynaecology and menopause; and which body will be responsible for report
19 May 2026
Target answer date
Date supplied by the official written-questions record.
1 Jun 2026
Answer published
The Renewed Women’s Health Strategy, published in April 2026, committed to redesigning clinical pathways for heavy menstrual bleeding, urogynaecology and menopause.These redesigned pathways will create roadmaps for health systems to use and adapt for loca...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
No later same-department questions indexed.
This is an absence in covered public data, not evidence that no follow-up occurred elsewhere.